Full history for every metric is available with a Kvantra account
Biotage AB (publ) (BIOT.ST)
Key financial summary
Financials in SEK| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | SEK m | 1,101 | 1,092 | 1,232 | 1,566 | 1,862 | 2,056 | 1,961 |
| Operating profit | SEK m | 383 | 312 | |||||
| Net profit | SEK m | 187 | 175 | 205 | 268 | 246 | 284 | 256 |
| EPS reported | SEK | 3.55 | 3.19 | |||||
| Operating cashflow per share | SEK | 5.16 | 5.16 | |||||
| Capex per share | SEK | 2.11 | 2.11 | |||||
| FCF per share | SEK | 3.05 | 3.05 | |||||
| Free cash flow | SEK m | 244 | 188 | |||||
| Net debt | SEK m | -284 | -270 | |||||
| Book value equity | SEK m | 4,113 | 3,846 | |||||
| Book value per share | SEK | 51.35 | 47.97 | |||||
| Number of shares | m | 80.1 | 80.18 | |||||
| DPS (TTM paid) | SEK | 1.65 | 1.65 |
Financial summary
Financials in SEK| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | 45.30 | - | |||||
| P/B LTM | x | 3.13 | 2.98 | |||||
| P/S LTM | x | 6.26 | 5.85 | |||||
| P/FCF LTM | x | 52.74 | 60.98 | |||||
| EV/EBITDA LTM | x | 23.93 | 22.80 | |||||
| EV/Sales LTM | x | 6.17 | 5.71 | |||||
| Earnings Yield LTM | % | 2.21% | 2.48% | |||||
| FCF Yield | % | 1.90% | 1.64% | |||||
| Quality | ||||||||
| ROE | % | 6.90% | 7.31% | |||||
| ROIC | % | 7.28% | 7.28% | |||||
| Operating margin | % | 18.63% | 18.63% | |||||
| Gross margin | % | 62.69% | 62.69% | |||||
| FCF/Sales | % | 11.87% | 11.87% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | +6.93% | +5.98% | |||||
| Sales Growth YoY | % | +10.42% | -1.01% | |||||
| Net Income Growth YoY | % | +15.45% | +8.47% | |||||
| FCF Growth | % | -5.43% | -37.95% | |||||
| Operating Profit Growth | % | +1.86% | -9.57% | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.99% | 1.15% | |||||
| Dividend Growth | % | +3.12% | - | |||||
| Payout Ratio | % | 45.07% | 50.08% | |||||
| FCF/Debt | x | 0.98 | 0.79 | |||||
| Net Debt/EBITDA | x | -0.35 | -0.35 | |||||
| EBIT/Net interest | x | 8.91 | 8.91 | |||||
| Net debt/market cap | % | -2.21% | -2.36% | |||||
| Net debt/Equity | x | -0.07 | -0.07 | |||||
| Gross debt/equity | x | 0.06 | 0.06 | |||||
Company overview
Biotage AB (publ), established in 1969 and based in Uppsala, Sweden, specializes in providing advanced separation technologies essential for fields such as organic and analytical chemistry, biomolecule research, and industrial scale-up applications. The company offers a comprehensive range of products, including solutions for organic and peptide synthesis, flash chromatography, evaporation, and work-up procedures, along with specialized systems, accessories, and various cartridges (normal, reversed, and specialty phase). Biotage also supplies solutions for plasmid and protein purification, encompassing antibody and tagged protein purification, automation systems, custom packing services, and diverse PhyTip columns. Additionally, they provide extensive sample preparation solutions tailored for clinical, bioanalytical, forensic, toxicology, doping control, environmental, and food and agriculture sectors, complemented by necessary consumables. Their offerings further include metal scavengers, reagents, and essential spare parts. Biotage serves a broad client base, including pharmaceutical and biotechnical companies, contract research and manufacturing organizations, government agencies, academic institutions, and various clinical, forensic, and academic laboratories. With a significant global footprint, the company operates in 70 countries across the Americas, Europe, the Middle East, Africa, and Asia Pacific.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Biotage AB (publ) (BIOT.ST)
Biotage AB (publ), established in 1969 and based in Uppsala, Sweden, specializes in providing advanced separation technologies essential for fields such as organic and analytical chemistry, biomolecule research, and industrial scale-up applications. The company offers a comprehensive range of products, including solutions for organic and peptide synthesis, flash chromatography, evaporation, and work-up procedures, along with specialized systems, accessories, and various cartridges (normal, reversed, and specialty phase). Biotage also supplies solutions for plasmid and protein purification, encompassing antibody and tagged protein purification, automation systems, custom packing services, and diverse PhyTip columns. Additionally, they provide extensive sample preparation solutions tailored for clinical, bioanalytical, forensic, toxicology, doping control, environmental, and food and agriculture sectors, complemented by necessary consumables. Their offerings further include metal scavengers, reagents, and essential spare parts. Biotage serves a broad client base, including pharmaceutical and biotechnical companies, contract research and manufacturing organizations, government agencies, academic institutions, and various clinical, forensic, and academic laboratories. With a significant global footprint, the company operates in 70 countries across the Americas, Europe, the Middle East, Africa, and Asia Pacific.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free